The estimated Net Worth of Gabriel R. Cappucci is at least $4.52 Million dollars as of 5 March 2020. Mr. Cappucci owns over 1,480 units of Teladoc Health Inc stock worth over $27,996 and over the last 9 years he sold TDOC stock worth over $3,763,673. In addition, he makes $725,488 as Senior Vice President - Finance at Teladoc Health Inc.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Mr. Cappucci TDOC stock SEC Form 4 insiders trading
Gabriel has made over 4 trades of the Teladoc Health Inc stock since 2017, according to the Form 4 filled with the SEC. Most recently he exercised 1,480 units of TDOC stock worth $10,804 on 5 March 2020.
The largest trade he's ever made was selling 22,294 units of Teladoc Health Inc stock on 16 April 2017 worth over $3,763,673. On average, Gabriel trades about 5,016 units every 151 days since 2016. As of 5 March 2020 he still owns at least 3,835 units of Teladoc Health Inc stock.
You can see the complete history of Mr. Cappucci stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Gabriel Cappucci biography
Gabriel R. Cappucci serves as Senior Vice President - Finance of the Company. Prior to joining the Company, Mr. Cappucci had a nearly 20-year career at Medco Health Solutions, Inc. where he held a variety of finance roles, including SVP & Controller, Chief Accounting Officer. Most recently, he was Chief Financial Officer of Enclara Pharmacia, a privately held company providing hospice pharmacy services. He is a graduate of Boston College’s Carroll School of Management. Mr. Cappucci is a Certified Public Accountant and a member of the American Institute of Certified Public Accountants.
What is the salary of Gabriel Cappucci?
As the Senior Vice President - Finance of Teladoc Health Inc, the total compensation of Gabriel Cappucci at Teladoc Health Inc is $725,488. There are 10 executives at Teladoc Health Inc getting paid more, with Jason Gorevic having the highest compensation of $7,995,690.
How old is Gabriel Cappucci?
Gabriel Cappucci is 57, he's been the Senior Vice President - Finance of Teladoc Health Inc since 2020. There are 7 older and 14 younger executives at Teladoc Health Inc. The oldest executive at Teladoc Health Inc is David Shedlarz, 71, who is the Independent Director.
What's Gabriel Cappucci's mailing address?
Gabriel's mailing address filed with the SEC is C/O TELADOC HEALTH, INC.,, 2 MANHATTANVILLE ROAD, SUITE 203, PURCHASE, NY, 10577.
Insiders trading at Teladoc Health Inc
Over the last 9 years, insiders at Teladoc Health Inc have traded over $190,385,368 worth of Teladoc Health Inc stock and bought 50,333 units worth $544,816 . The most active insiders traders include Hemant Taneja, Glen Tullman und Jason N Gorevic. On average, Teladoc Health Inc executives and independent directors trade stock every 6 days with the average trade being worth of $111,413. The most recent stock trade was executed by Andrew Turitz on 4 September 2024, trading 20,773 units of TDOC stock currently worth $150,812.
What does Teladoc Health Inc do?
Teladoc Health empowers all people everywhere to live their healthiest lives by transforming the healthcare experience. As the world leader in whole-person virtual care, Teladoc Health uses proprietary health signals and personalized interactions to drive better health outcomes across the full continuum of care, at every stage in a person’s health journey. Ranked best in KLAS for Virtual Care Platforms in 2020, Teladoc Health leverages more than a decade of expertise and data-driven insights to meet the growing virtual care needs of consumers and healthcare professionals.
What does Teladoc Health Inc's logo look like?
Complete history of Mr. Cappucci stock trades at Teladoc Health Inc
Teladoc Health Inc executives and stock owners
Teladoc Health Inc executives and other stock owners filed with the SEC include:
-
Jason Gorevic,
Chief Executive Officer, Director -
David Sides,
Chief Operating Officer -
Mala Murthy,
Chief Financial Officer -
Lewis Levy,
Chief Medical Officer -
Stephanie Verstraete,
Chief Marketing Officer -
Adam Vandervoort,
Chief Legal Officer and Secretary -
Jason Nathanial Gorevic,
CEO & Director -
Claus Torp Jensen Ph.D.,
Chief Innovation Officer -
Mala Murthy,
Chief Financial Officer -
Adam Christian Vandervoort,
Chief Legal Officer & Sec. -
Gabriel Cappucci,
Senior Vice President - Finance -
David Snow,
Independent Chairman of the Board -
David Shedlarz,
Independent Director -
Thomas McKinley,
Independent Director -
William Frist,
Independent Director -
Kenneth Paulus,
Independent Director -
Mark Smith,
Independent Director -
Catherine Jacobson,
Independent Director -
Andrew Turitz,
Senior Vice President of Business Development -
Michelle Bucaria,
Chief Human Resource Officer -
Mike Waters,
Chief Operating Officer -
Arnnon Geshuri,
Chief HR Officer -
Andrew Turitz,
Sr. VP of Corp. Devel. -
Courtney Kraemer McLeod,
Director of Communication -
Patrick Thomas Feeley C.F.A., CPA,
VP of Investor Relations -
Richard J. Napolitano,
Sr. VP, Chief Accounting Officer & Controller -
Dr. George Byron Brooks,
Co-Founder -
Stephany Verstraete,
Chief Marketing Officer & Engagement Officer -
James L. Cave,
INTERIM CAO -
Tom Mawhinney,
Director -
Arneek Multani,
Director -
Iii Lp Chp,
10% owner -
Iii Lpchp Iii Management, L...,
-
James K Outland,
Director -
Martin R Felsenthal,
Director -
Michael Goldstein,
Director -
Michael H. King,
Chief Sales Officer -
Peter N. Nieves,
EVP and CRO -
Capital Management Vi, L.L....,
-
Helen Darling,
Director -
Iii Management, L.L.C. Chp,
10% owner -
Dana G Jr. Mead,
Director -
Arnnon Geshuri,
CHIEF PEOPLE OFFICER -
Brian P Mcandrews,
Director -
Mark Hirschhorn,
Executive VP and CFO -
Peter A Mcclennen,
President -
Venture Partners Ii, L.P.Hl...,
-
Karen L Daniel,
Director -
Dgf Associates, Llckpcb Dig...,
-
Vidya Raman Tangella,
CHIEF MEDICAL OFFICER -
Laizer Kornwasser,
Advisor to the CEO -
Christopher Caridi,
Chief Accounting Officer -
Richard J Napolitano,
CHIEF ACCOUNTING OFFICER -
Yulun Wang,
Head of Research & Development -
Hemant Taneja,
Director -
Glen Tullman,
Director -
Christopher Bischoff,
-
Jason Eric Evans,
Director -
Claus Torp Jensen,
CHIEF INNOVATION OFFICER -
Daniel Trencher,
CHIEF STRATEGY OFFICER -
Stephany Verstraete,
CHIEF MARKETING OFFICER -
Michael Willem Waters,
CHIEF OPERATING OFFICER -
Nikolaos P. Nanis,
Chief Technology Officer -
Sandra L Fenwick,
Director -
Charles Iii Divita,
CHIEF EXECUTIVE OFFICER